TR199901307T2 - Oral skuam�z h�cre karsinomu i�in l�kotrien antagonistleri - Google Patents

Oral skuam�z h�cre karsinomu i�in l�kotrien antagonistleri

Info

Publication number
TR199901307T2
TR199901307T2 TR1999/01307T TR9901307T TR199901307T2 TR 199901307 T2 TR199901307 T2 TR 199901307T2 TR 1999/01307 T TR1999/01307 T TR 1999/01307T TR 9901307 T TR9901307 T TR 9901307T TR 199901307 T2 TR199901307 T2 TR 199901307T2
Authority
TR
Turkey
Prior art keywords
lycotriene
antagonists
oral squamous
cell carcinoma
squamous cell
Prior art date
Application number
TR1999/01307T
Other languages
English (en)
Turkish (tr)
Inventor
H. Fleisch Jerome
T. Jackson William
S. Sawyer Jason
Original Assignee
Eli Lilly And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly And Company filed Critical Eli Lilly And Company
Publication of TR199901307T2 publication Critical patent/TR199901307T2/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/194Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
TR1999/01307T 1996-12-13 1997-12-02 Oral skuam�z h�cre karsinomu i�in l�kotrien antagonistleri TR199901307T2 (xx)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3426996P 1996-12-13 1996-12-13
US4087497P 1997-03-21 1997-03-21

Publications (1)

Publication Number Publication Date
TR199901307T2 true TR199901307T2 (xx) 1999-08-23

Family

ID=26710754

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1999/01307T TR199901307T2 (xx) 1996-12-13 1997-12-02 Oral skuam�z h�cre karsinomu i�in l�kotrien antagonistleri

Country Status (14)

Country Link
EP (1) EP0964683A4 (de)
JP (1) JP2001509142A (de)
KR (1) KR20000069452A (de)
CN (1) CN1245429A (de)
AU (1) AU726215B2 (de)
CA (1) CA2274855A1 (de)
EA (1) EA002742B1 (de)
IL (1) IL130304A0 (de)
NO (1) NO992846L (de)
NZ (1) NZ335922A (de)
PL (1) PL334241A1 (de)
TR (1) TR199901307T2 (de)
UA (1) UA47505C2 (de)
WO (1) WO1998025615A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002009700A1 (en) 2000-07-28 2002-02-07 Cancer Research Technology Limited Cancer treatment by combination therapy
GB0121285D0 (en) 2001-09-03 2001-10-24 Cancer Res Ventures Ltd Anti-cancer combinations
GB2386836B (en) 2002-03-22 2006-07-26 Cancer Res Ventures Ltd Anti-cancer combinations
GB2394658A (en) 2002-11-01 2004-05-05 Cancer Rec Tech Ltd Oral anti-cancer composition
US8093253B2 (en) * 2008-03-06 2012-01-10 Hoffmann-La Roche Inc. Leukotriene B4 inhibitors
KR101898879B1 (ko) 2014-03-05 2018-09-14 재단법인 진안홍삼연구소 홍삼 가공 추출물을 유효성분으로 함유하는 구강편평세포암의 예방, 개선 또는 치료를 위한 조성물

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6372648A (ja) * 1986-09-16 1988-04-02 Sumitomo Pharmaceut Co Ltd 新規不飽和脂肪酸誘導体
PH30449A (en) * 1991-11-25 1997-05-28 Lilly Co Eli Substituted phenyl phenol leukotriene antagonists
CZ276694A3 (en) * 1991-11-25 1995-11-15 Lilly Co Eli Process for preparing diphenyl derivative

Also Published As

Publication number Publication date
IL130304A0 (en) 2000-06-01
UA47505C2 (uk) 2002-07-15
NO992846D0 (no) 1999-06-11
KR20000069452A (ko) 2000-11-25
CN1245429A (zh) 2000-02-23
JP2001509142A (ja) 2001-07-10
NZ335922A (en) 2000-12-22
EA002742B1 (ru) 2002-08-29
WO1998025615A1 (en) 1998-06-18
AU7845198A (en) 1998-07-03
AU726215B2 (en) 2000-11-02
EA199900543A1 (ru) 2000-02-28
EP0964683A1 (de) 1999-12-22
EP0964683A4 (de) 2002-08-14
PL334241A1 (en) 2000-02-14
NO992846L (no) 1999-06-11
CA2274855A1 (en) 1998-06-18

Similar Documents

Publication Publication Date Title
EE200100167A (et) 4-amino-asendatud 2-asendatud 1, 2, 3, 4-tetrahüdrokinoliinid kui CETP inhibiitorid
BR9810342A (pt) Novos compostos imidazola substituìdos
DE69917296D1 (de) Neue substituierte triazolverbindungen
PT998460E (pt) Novos derivados de tetrazole
DK0928362T3 (da) Blokerende sammensætning til anvendelse i en underjordisk formation
NO20011429L (no) Fremgangsmåte for å legge syntetisk gress
TR200100189T2 (tr) Hücre yapışması engelleyici iltihaplanmaya karşı bileşikler
ATE224386T1 (de) Neue in 6-position substituierte phenanthridine
TR200000740T2 (tr) Dişleri beyazlatmak için metod ve kompozisyonlar.
ATE297898T1 (de) 4-carboxamino-2-subsitutierte-1,2,3,4- tetrahydrochinoline als cetp inhibitoren
EA200100732A1 (ru) Противовоспалительные и иммуносупрессорные соединения, ингибирующие клеточную адгезию
TR200002345T2 (tr) Glukokortikoit seçiçi antienflamatuar ajanlar
ATE510553T1 (de) Beta-2-glycoprotein 1 als angiogenesehemmer
MY129445A (en) Compositions for treating inflammatory response
EE200100039A (et) Ftalasiinderivaadid kui fosfodiesteraas-4 inhibiitorid
TR200102041T2 (tr) Progesteron reseptör bağlama aktif maddeleri olarak ikameli 2-arilimino heterosaykıllar
ATE245623T1 (de) Verbindungen mit zytoprotektiver wirkung
TR199901307T2 (xx) Oral skuam�z h�cre karsinomu i�in l�kotrien antagonistleri
EE200000733A (et) Tetrahüdrokinoliini derivaadid kui glütsiini antagonistid
AR026901A1 (es) Peptidos con n-alquilacion que tienen actividad antiangiogenica
EA200300468A1 (ru) Подавление зависимости опухолевых клеток от фактора роста
DE3873278D1 (de) Aryl-substituierte thiophen-3-ole, ihre derivate und analoge als lipoxygenase-inhibitoren.
DE69923854D1 (de) Rar-antagonisten zur verhütung für männer
BR9902101B1 (pt) grade de eletrodo para baterias de chumbo.
AU2002224431A1 (en) 2-substituted heterocyclic compounds and their use in treating multidrug resistance